Back
Scenic Biotech

Scenic Biotech

scenicbiotech.com

Scenic Biotech is a pre-clinical biotech company using their proprietary platform technology to identify novel drug targets based on genetic modifiers for patients with rare diseases and cancers.

What
Life Sciences
When
Mar 2017
CEO
Oscar Izeboud
Status
Private
Investment
Active

Latest News

All Company News
Portfolio NewsScenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882Portfolio NewsScenic Biotech enters cooperative research and development agreement with the National Institutes of Health for genetic modifier-based treatment approach for Niemann-Pick Type C DiseasePortfolio NewsScenic Biotech strengthens drug discovery expertise in management team with the addition of Kristof Van EmelenPortfolio NewsScenic Biotech appoints Jens Würthner as Chief Medical OfficerPortfolio NewsScenic Biotech and the Barth Syndrome Foundation announce partnership to explore genetic modifiers to find tailored treatment for complex rare disease
PreviousNext